PDF herunterladen
CC BY-NC-ND 4.0 · Journal of Health and Allied Sciences NU 2016; 06(01): 098-101
DOI: 10.1055/s-0040-1708628
Case Report

Low Grade Endometrial Stromal Sarcoma : Report of a Rare Uterine Malignancy

Harish Shetty
1   Professor & HOD, Department of Obstetrics & Gynecology, K.S.Hegde Medical Academy, Nitte University, Mangalore, Karnataka, India
,
Prasanna K. Kumar Shetty
2   Professor, Department of Obstetrics & Gynecology, K.S.Hegde Medical Academy, Nitte University, Mangalore, Karnataka, India
,
Aparna Rajesh
3   Associate Professor, Department of Obstetrics & Gynecology, K.S.Hegde Medical Academy, Nitte University, Mangalore, Karnataka, India
,
J.C. Spandana
4   Postgraduate, Department of Obstetrics & Gynecology, K.S.Hegde Medical Academy, Nitte University, Mangalore, Karnataka, India
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
  als PDF herunterladen Lizenzen und Reprints

Abstract

Endometrial stromal sarcoma (ESS) is a rare malignant tumor, occurring in the age group of 40-50 years. We report a case of lowgrade ESS in a 42 year old women, presenting as rapid enlargement of uterus associated with excessive vaginal bleeding. ESS can be mistaken for leiomyoma. Histopathological examination remains the mainstay for diagnosis of such tumors. Although rare, ESS should be considered in the differential diagnosis of all women who present with a rapid enlargement of a uterine leiomyoma.

Keywords:

endometrial stromal sarcoma - perimenopausal - menorrhagia - leiomyoma


Publikationsverlauf

Artikel online veröffentlicht:
22. April 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Evans HL: Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma. Cancer 50: 2170-2182, 1982.
  • 2 Sorbe B and Johansson B: Prophylactic pelvic irradiation as part of primary therapy in uterine sarcomas. Int J Oncol32: 1111-1117, 2008.
  • 3 Yoney A, Eren B, Eskici S, Salman A and Unsal M: Retrospective analysis of 105 cases with uterine sarcoma. Bull Cancer 95: E10-17, 2008.
  • 4 Tavassoli FA, Devilee P, WHO classification of pathology and genetics of tumours of the breast and female genital organs. In Tavasssoli FA, Devilee P, editors, Lyon, France: IARC press; 2003. p. 233-236.
  • 5 Norris HJ, Taylor HB. Mesenchymal tumours of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumors. Cancer 1966; 19: 755-766.
  • 6 Gadducci A, Cosio S, Romanini A, Genazzani AR. The management of patients with uterine sarcoma: a debated clinical challenge. Crit rev oncolHematol 2008;65: 129-242.
  • 7 Dos Santos LA, Garg K Diaz JP, Soslow RA, Hensley ML, Alekttiar KM. incidence of LN and adnexal metastasis in endometrial stromal sarcoma. gynecolOncol 2011: 121: 319-322.
  • 8 Micci F, Panagopoulos I, Bjerkehagen B, Heim S. Cosistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma. Cancer Res2006;66:107-12.
  • 9 Halbwed I, Ullmann R, Kremser ML, Man YG, Moud NI, Lax S. chromosomal alterations in low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma as detected by comparative genomic hybridization. GynecolOncol 2005;2:582-7. th
  • 10 Berek JS(ed). Novaks Gynaecology 14 edition. Philadelphia, Lippincott Williams and Wilkins. 2006:1382-84.
  • 11 Broadman CH, Webb MJ, Jefferies JA. Low grade endometrial stromal sarcoma of the ectocervix after therapy for breast cancer. GynecolOncol 2000;79(1): 120-3.
  • 12 Livi L, Paiar F, Shah N, Blake P, VillanucciA,Amunni G. Uterine sarcoma: twenty-seven years of experience. Int J Radiant OncolBiolPhys 2003;57(5):1366-73.
  • 13 Shafi M, Luesley DM, Jorda JA. Gynecological oncology. London, England: Churchill Livingstone; 2001: 120-121.
  • 14 Hendrickson MR,Tavassoli FA, Kempson RL. mesenchymal tumours and related lesions. In :Tavassoli FA, Devilee P, eds. Pathology and genetics of tumours of breast and female genital organs. Lyon, France: IARC Press; 2004:233-236. World health organization classification of tumours.
  • 15 Evans HL, Chawla SP, Simpson C. smooth muscle neoplasms of the uterus other than ordinary leiomyoma: a study of 46 cases, with emphasis on diagnostic criteria and prognostic factors. Cancer. 1988;62:2239-2247.
  • 16 Al-Nafussi Al. tumour Diagnosis: Practical approach and pattern nd analysis. 2 ed. London, England: oxford University Press;2005:424- 429.
  • 17 Baker P, Olivia E. Endometrial stromal tumors of the uterus: A practical approach using conventional morphology and ancillary techniques. J ClinPathol 2007;60(3):235-43.
  • 18 Linder T, Pink D, Kretzschmar A, Mrozek A, Patience PC, Reichardt P. hormone treatment of endometrial stromal sarcomas: a possible indication for aromatase inhibitors. J ClinOncol 2005; 23: 16s:9057.
  • 19 Husseiny GE, Bareedy NA, Mourad WA, Mohamed G, Shoukri M, Subhi J. prognostic factors and treatment modalities in uterine sarcoma. Am J ClinOncol 2002;25(3):256-60.
  • 20 Rovirossa A, Ascaso, Ordi J, Abellana, Arenas M, Lejarcegui JA. is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? A retrospective study of prognostic factors of 60 patients stratified by stages. Int J Radiant OncolBiolPhys 2002;52(5):1320-9.